Izzy Judd: ‘Music let my brother in a coma connect with us’
Rupert Johnston was left brain damaged after a car crash, but his prolific musical ability lives on.
Rupert Johnston was left brain damaged after a car crash, but his prolific musical ability lives on.
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
Hospitals dealing with influx of kids with respiratory illnesses – CBS News Watch CBS News The new year is bringing a surge in cases of RSV and the flu among kids. Hospitals across the country are dealing with a surge in cases and, in some cases, a lack of beds. Janet Shamlian reports. Be the…
In the United States, strokes are a top cause of death and a major cause of disability, according to the American Stroke Association. This is a scary reality, especially since many of the stroke risk factors are pretty silent (like high cholesterol and high blood pressure) ― until they’re not. But just because some of…
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Winter officially begins Thursday, and with the cold season comes an expected rise in rates of flu and Covid, said Dr. Mandy Cohen, the director of the Centers for Disease Control and Prevention. The U.S. is seeing a “sharp increase” in flu levels right now, particularly in the south, Cohen said Wednesday in an interview….
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer by half after roughly three years,…